ATE348830T1 - Kryptatverbindungen und verfahren zur diagnose und therapie - Google Patents
Kryptatverbindungen und verfahren zur diagnose und therapieInfo
- Publication number
- ATE348830T1 ATE348830T1 AT00902480T AT00902480T ATE348830T1 AT E348830 T1 ATE348830 T1 AT E348830T1 AT 00902480 T AT00902480 T AT 00902480T AT 00902480 T AT00902480 T AT 00902480T AT E348830 T1 ATE348830 T1 AT E348830T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- relates
- present
- optionally substituted
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 239000002738 chelating agent Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- -1 nitro, nitroso, amino Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 229910052698 phosphorus Inorganic materials 0.000 abstract 1
- 238000000163 radioactive labelling Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1063—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from stomach or intestines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1072—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP8038A AUPP803899A0 (en) | 1999-01-05 | 1999-01-05 | Cryptate compounds and methods for diagnosis and therapy. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE348830T1 true ATE348830T1 (de) | 2007-01-15 |
Family
ID=3812244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00902480T ATE348830T1 (de) | 1999-01-05 | 2000-01-05 | Kryptatverbindungen und verfahren zur diagnose und therapie |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6869589B1 (de) |
| EP (1) | EP1147111B1 (de) |
| AT (1) | ATE348830T1 (de) |
| AU (1) | AUPP803899A0 (de) |
| DE (1) | DE60032460T2 (de) |
| ES (1) | ES2278590T3 (de) |
| WO (1) | WO2000040585A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA981883B (en) * | 1997-03-07 | 1998-09-01 | Univ Kansas | Catalysts and methods for catalytic oxidation |
| US20050192195A1 (en) * | 2002-08-27 | 2005-09-01 | Busch Daryle H. | Catalysts and methods for catalytic oxidation |
| EP2370447B1 (de) | 2008-12-02 | 2016-07-27 | The University of Melbourne | Stickstoffhaltige makrocyclische konjugate als radiopharmaka |
| US9403875B2 (en) * | 2009-01-27 | 2016-08-02 | University Of Southern California | Cage-like bifunctional chelators, copper-64 radiopharmaceuticals and PET imaging using the same |
| AU2012278938A1 (en) * | 2011-07-07 | 2013-03-07 | Australian Nuclear Science And Technology Organisation | Cryptate compounds |
| WO2016163727A2 (ko) | 2015-04-07 | 2016-10-13 | 경북대학교 산학협력단 | 황화수소 검출용 방사성 프로브 |
| JP7144451B2 (ja) * | 2017-06-06 | 2022-09-29 | クラリティー・ファーマシューティカルズ・リミテッド | 放射性医薬品、放射線造影剤及びそれらの使用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4741900A (en) * | 1982-11-16 | 1988-05-03 | Cytogen Corporation | Antibody-metal ion complexes |
| US5364613A (en) * | 1989-04-07 | 1994-11-15 | Sieving Paul F | Polychelants containing macrocyclic chelant moieties |
| WO1995031202A1 (en) * | 1994-05-17 | 1995-11-23 | Commonwealth Scientific And Industrial Research Organisation | Cage compounds, processes for their preparation and their use as antiviral agents |
-
1999
- 1999-01-05 AU AUPP8038A patent/AUPP803899A0/en not_active Abandoned
-
2000
- 2000-01-05 ES ES00902480T patent/ES2278590T3/es not_active Expired - Lifetime
- 2000-01-05 AT AT00902480T patent/ATE348830T1/de active
- 2000-01-05 EP EP00902480A patent/EP1147111B1/de not_active Expired - Lifetime
- 2000-01-05 DE DE60032460T patent/DE60032460T2/de not_active Expired - Lifetime
- 2000-01-05 US US09/869,777 patent/US6869589B1/en not_active Expired - Lifetime
- 2000-01-05 WO PCT/AU2000/000003 patent/WO2000040585A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1147111B1 (de) | 2006-12-20 |
| ES2278590T3 (es) | 2007-08-16 |
| DE60032460D1 (de) | 2007-02-01 |
| US6869589B1 (en) | 2005-03-22 |
| EP1147111A4 (de) | 2002-05-02 |
| DE60032460T2 (de) | 2007-11-15 |
| EP1147111A1 (de) | 2001-10-24 |
| WO2000040585A1 (en) | 2000-07-13 |
| AUPP803899A0 (en) | 1999-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200101133A1 (ru) | Способ ингибирования агрегации амилоидных белков и визуализации амилоидных отложений с использованием производных изоиндолина | |
| EP2201945A3 (de) | Verwendung von substituierten 2-Aminoacetamiden zur Behandlung oder Verbesserung von Angstzuständen | |
| ATE374769T1 (de) | Beta-lactam-verbindungen, verfahren zu deren herstellung und serumcholesterinsenkende mittel, die diese verbindungen enthalten | |
| BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
| CA2507545A1 (en) | Use of furfural derivatives as anti-sickling agents | |
| CY1109037T1 (el) | Πιπεραζινες χρησιμες για θεραπεια πονου | |
| WO2005030766A8 (en) | Phenyl - carboxamide compounds useful for treating pain | |
| NO20082747L (no) | Arylisoksazol-4-yl-imidazolderivater | |
| ATE246180T1 (de) | Benzofuranon-derivate und verfahren zu ihrer herstellung | |
| ATE348830T1 (de) | Kryptatverbindungen und verfahren zur diagnose und therapie | |
| TR200101868T2 (tr) | Sülfonamit hidroksamatlar. | |
| TR200103551T2 (tr) | Amiloid protein birikimini önleme ve amiloid tortularını görüntüleme metodu | |
| RU2007143512A (ru) | ИМИДАЗО[1,2-a]ПИРИДИНОВЫЕ ПРОИЗВОДНЫЕ, КОТОРЫЕ МОЖНО ИСПОЛЬЗОВАТЬ В КАЧЕСТВЕ ИНГИБИТОРОВ ПЕПТИДДЕФОРМИЛАЗЫ | |
| ATE234086T1 (de) | Creatine derivate für asthma | |
| NZ502785A (en) | Use of NR1A/2B site-selective NMDA receptor antagonist compounds for treating disease-related or drug-induced dyskinesias | |
| ATE219491T1 (de) | Acronycinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| DE69725167D1 (de) | N-benzolsulfonyl-l-prolin derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung | |
| ATE374366T1 (de) | Aminophenoxyacetamid derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE293591T1 (de) | Neue n-(2-phenyl-3-aminopropyl)naphtamide | |
| NO20032411D0 (no) | Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens | |
| CY1108259T1 (el) | Ανταγωνιστες υποδοχεα διεγερτικου αμινοξεος | |
| WO2001080847A3 (en) | Combination of carboxyalkylethers with antihypertensives and pharmaceutical use | |
| EA200100157A2 (ru) | Новые производные арил- или гетероарилхинолинилфосфоновой кислоты, способ их получения и содержащие их фармацевтические композиции | |
| DE60114170D1 (de) | Verfahren zur herstellung von decahydro-2a,4a,6a,8a-tetraazacyclopent[fg]acenaphthylene und dessen funktionelle derivate | |
| RU2002126568A (ru) | Средство для лечения заболевания, обусловленного стенозирующим поражением сосудов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1147111 Country of ref document: EP |